info

Showing posts with label Spinal Cord Injury Intensity Modifies the Expression of Inflammation-Related Gene Expression after Immunization with Neural Derived Peptides. Show all posts
Showing posts with label Spinal Cord Injury Intensity Modifies the Expression of Inflammation-Related Gene Expression after Immunization with Neural Derived Peptides. Show all posts

Wednesday, 11 April 2018

Spinal Cord Injury Intensity Modifies the Expression of Inflammation-Related Gene Expression after Immunization with Neural Derived Peptides





Previous studies revealed that the intensity of Spinal Cord Injury (SCI) plays a key role in the therapeutic effects induced by Immunizing With Neural-Derived Peptides (INDP), as severe injuries abolish the beneficial effects induced by INDP. In the present study, we analyzed the expression of some inflammation-related genes (IL6, IL12, IL-1β, IFNɣ, TNFα, IL-10, IL-4, and IGF-1) by quantitative PCR in rats subjected to SCI and INDP. We investigated the expression of these genes after a moderate or severe contusion. In addition, we evaluated the effect of INDP by utilizing2 different peptides: A91 and Cop-1. After moderate injury, both A91 andCop-1 eliciteda pattern of genes characterized by a significant reduction of IL6, IL1β,andTNFα but an increase in IL10, IL4, and IGF-1expression. There was no effect on IL-12 and INFɣ. In contrast, the opposite pattern was observed when rats were subjected to a severe spinal cord contusion. Immunization with either peptide caused a significant increase in the expression of IL-12, IL-1β, IFNɣ, (pro-inflammatory genes), and IGF-1. There was no effect on IL-4 and IL-10 compared to controls. After a moderate SCI, IND Preduced pro-inflammatory gene expression, and generated a microenvironment prone to neuroprotection. Nevertheless, severe injury elicits the expression of pro-inflammatory genes that could be aggravated by INDP. These findings correlate with our previous results demonstrating that severe injury inhibits the beneficial effects of protective autoimmunity.

TB Treatment Success Rate in Ethiopia: Key Findings & Challenges

Tuberculosis (TB) remains a major global health issue , infecting one-third of the world's population . Despite efforts, Ethiopia's...